(Total Views: 461)
Posted On: 02/09/2022 10:19:47 AM
Post# of 157591
How common is if for a partnership to request the removal of a CEO. This is what I can’t really get my head around. Why was NP removed?
Wouldn’t we want to hold off until everything was in line then make the announcement. Keep the CEO around for a smooth transition? Or did our upcoming partner see that NP talked to share holders too much and didn’t want the communication to continue?
The timing of everything is off. It’s really hard to make sense of what exactly is taking place.
Wouldn’t we want to hold off until everything was in line then make the announcement. Keep the CEO around for a smooth transition? Or did our upcoming partner see that NP talked to share holders too much and didn’t want the communication to continue?
The timing of everything is off. It’s really hard to make sense of what exactly is taking place.


Daniel Rizzo
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf